{"version":"1.0","provider_name":"Site da Brakke Consulting","provider_url":"https:\/\/brakkeconsulting.com\/pt","title":"News from Brakke Consulting","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"55tZocABK1\"><a href=\"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-january-31-2025\/\">Mirante de Brakke 31 de janeiro de 2025<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-january-31-2025\/embed\/#?secret=55tZocABK1\" width=\"600\" height=\"338\" title=\"\u201cBrakke Viewpoint 31 de janeiro de 2025\u201d - Site da Brakke Consulting\" data-secret=\"55tZocABK1\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/brakkeconsulting.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>","description":"It was great to see many of our News &amp; Notes subscribers at the VMX conference in Orlando this week and we are very grateful to those that attended the 2025 Animal Health Industry Overview on Monday afternoon.\u00a0 This was the best attended session we have ever had, so thanks to all of you for your support. As I walked the exhibition hall and talked to the exhibitors, everyone seemed to be positive about 2025, especially those with new products to launch.\u00a0 Elanco\u2019s combination parasiticide, Credlio Quattro was launched and the company was taking orders, along with recently approved Zenrelia for atopic dermatitis.\u00a0 There was some buzz around Merck\u2019s injectable Bravecto parasiticide and possible dermatology product later in the year. Another notable launch was IDEXX\u2019s new lymphoma early detection test \u2013 IDEXX Cancer Dx &#8211; notable for its affordability and ability to expand on to other cancers.\u00a0 There was some talk about Zoetis\u2019s Librela for canine OA pain, but my sense is that veterinarians are simply learning how to use it \u2013 my 10-year-old athletic Labrador retriever is doing fantastic after his third injection. We will hold our Industry Overview at WVC in Las Vegas on March 3rd, so if you missed the one in Orlando, you still have a chance to attend.\u00a0 Hope to see you there. Bob Jones"}